REQUEST A DEMO
Total
USD $0.00
Search more companies

Inverfarma Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Inverfarma Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Inverfarma Sas is based in Colombia. The head office is in Cota. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on August 12, 1994. 52 (2024) employees currently work for Inverfarma Sas. There was a net sales revenue drop of 17.26% reported in Inverfarma Sas’s latest financial highlights for 2023. Its’ total assets recorded a negative growth of 7.03%. The net profit margin of Inverfarma Sas decreased by 1.58% in 2023.

Headquarters
Zona Franca Intexzona Bd 23
Cota; Cundinamarca;

Contact Details: Purchase the Inverfarma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Inverfarma Sas report to view the information.
Outstanding Shares:
Purchase the Inverfarma Sas report to view the information.
Registered Capital:
Purchase the Inverfarma Sas report to view the information.
Incorporation Date:
August 12, 1994
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Inverfarma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-17.26%
Total operating revenue
-20.47%
Operating profit (EBIT)
-62.27%
EBITDA
-46.8%
Net Profit (Loss) for the Period
-60.58%
Total assets
-7.03%
Total equity
2.65%
Operating Profit Margin (ROS)
-6.32%
Net Profit Margin
-1.58%
Return on Equity (ROE)
-3.17%
Debt to Equity Ratio
-2.02%
Quick Ratio
0.15%
Cash Ratio
0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?